SC

Sai Chand Yarra

Active Director Director DIN 09097496
DIN 09097496 First appointment Mar 2021 Primary industry Home Appliances
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Sai Chand Yarra

Data last updated:

Sai Chand Yarra is a Director at Spyro Pharmaceuticals Private Limited (since 2021). The company operates in Home Appliances. Spyro Pharmaceuticals Private Limited reported revenue of ₹23.7 Lakh (FY 2025).

DIN 09097496
Primary Designation Director
Industry Home Appliances
First Appointment 09 Mar 2021
Oldest Company Age 5 yrs
Largest company Spyro Pharmaceuticals Private Limited · ₹23.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Mar 20212021₹23.7 Lakh (FY 2025)Active

Board colleagues of Sai Chand Yarra

Directorship timeline

Open interactive timeline →
Spyro Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sai Chand Yarra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sai Chand Yarra

Sai Chand Yarra currently holds 1 directorship: Spyro Pharmaceuticals Private Limited (Director, since 09 Mar 2021, revenue ₹23.7 Lakh (FY 2025)).

Sai Chand Yarra was first appointed on 09 Mar 2021 as Director at Spyro Pharmaceuticals Private Limited.

The current boards of Sai Chand Yarra's companies include Gopi Krishna Cheemaladinne (Spyro Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available